Search

everythinglearnresearchcommunity

for

Search:↓

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

Hydroxychloroquine may help COVID-19 patients with lupus.

New insights show Lichen Planopilaris is a rare, scarring hair loss condition, hard to treat, mainly affecting middle-aged women, and significantly impacts mental health.

Bimatoprost is safe but not effective for severe eyelash loss from alopecia areata, possibly helping those with less loss.

Patients with lupus nephritis and COVID-19 can improve with proper treatment.

Stem cells and their secretions could potentially treat stress-induced hair loss, but more human trials are needed.

Alopecia areata may be treated by restoring hair follicle immune privilege and adjusting immune responses.

Alopecia areata is a genetic and immune-related hair loss condition that is often associated with other autoimmune diseases and does not typically cause permanent damage to hair follicles.

New targeted therapies for hair loss from alopecia areata show promise, with personalized treatment expected in the future.

Vitamin A affects hair loss and immune response in alopecia areata.

Skin problems are common in lupus patients and should be treated early to prevent worsening.

North American ginseng extract helped regrow hair in balding mice.

Diphencyprone is effective for treating patchy hair loss in alopecia areata, but tacrolimus is not.

Using a 308-nm excimer lamp with minoxidil promotes hair growth in Alopecia Areata patients, especially younger ones or those with smaller bald spots.

The study found that a specific genetic variation in the TNFα gene is significantly linked to Alopecia Areata in the Jordanian Arab population.

Further research is needed to understand how the microbiome affects hair loss in Alopecia Areata.

Systemic corticosteroids might help treat hair loss caused by alemtuzumab in MS patients.

Certain IL-18 gene variations may increase the risk of alopecia areata.

Stem Cell Educator therapy helps regrow hair and improve life quality in alopecia areata patients.

Blocking Janus kinase 1 helps stop inflammation and regrow hair, making it a good treatment for hair loss from alopecia areata.

A 44-year-old woman with Down's syndrome was diagnosed with both rheumatoid and gouty arthritis and treated with multiple medications.

Oral methylprednisolone pulse therapy helped an 11-year-old regrow 80% of his hair in six months.

A woman with alopecia totalis regrew dark hair in bands after using a corticosteroid ointment.

Japanese patients with alopecia areata often have a higher BMI and consume more vitamin C, fruit, and retinol, which may affect their condition's development or severity.

Inactive stem cells in hair follicles and muscles can avoid detection by the immune system.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

New cytokine-targeted therapies show promise for treating alopecia areata.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Blocking SCD1 in the skin with XEN103 shrinks sebaceous glands in mice.